PTDM has been associated with greater mortality and increased infections in different transplant groups using different diagnostic criteria. Greater glucose monitoring during all hospitalizations has revealed significant glucose intolerance in the majority of recipients immediately after transplant. As a result, the international consensus panel reviewed its earlier guidelines and recommended delaying screening and diagnosis of PTDM until the recipient is on stable doses of immunosuppression after discharge from initial transplant hospitalization. The group cautioned that whereas hemoglobin A1C has been adopted as a diagnostic criterion by many, it is not reliable as the sole diabetes screening method during the first year after transplant. Risk factors for PTDM include many of the immunosuppressant medications themselves as well as those for type 2 diabetes. The provider managing diabetes and associated dyslipidemia and hypertension after transplant must be careful of the greater risk for drug-drug interactions and infections with immunosuppressant medications.
FOR MORE DETAILS PLEASE CONTACT US AT 9811459842.
- Best Post Transplant Care Diabetes Treatment in South Delhi
- Best Post Transplant Care Diabetes Treatment in Safdarjung
- Best Post Transplant Care Diabetes Treatment in Hauz Khas
- Best Post Transplant Care Diabetes Treatment in Panchsheel
